Capreomycin-induced serum electrolyte abnormalities.
D000328:Adult; D000368:Aged; D000471:Alkalosis / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000009:adverse effects*; D004977:Ethambutol / Q000009:adverse effects; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000139:chemically induced; D006996:Hypocalcemia / Q000139:chemically induced*; D007008:Hypokalemia / Q000139:chemically induced*; D007010:Hyponatremia / Q000139:chemically induced; D007538:Isoniazid / Q000009:adverse effects; D008274:Magnesium / Q000097:blood*; D008297:Male; D012083:Renin / Q000097:blood; D012964:Sodium / Q000652:urine; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D004977:Ethambutol; D012964:Sodium; D012083:Renin; D008274:Magnesium; D007538:Isoniazid